Information updates

ASCIA Oral Immunotherapy (OIT) for Food Allergy Update

3 December 2020

Oral immunotherapy (OIT) is a potential treatment for food allergy. It involves giving gradually increasing amounts of food allergen under medical supervision and continued daily consumption of the food allergen. If the goal of desensitisation is reached, there is a temporary increase in the amount of food allergen that can be consumed before an allergic reaction occurs.

Food allergy OIT is an emerging treatment, and there are currently several clinical trials of OIT and other treatments for food allergy underway in Australia and other countries.

ASCIA information on OIT for food allergy www.allergy.org.au/patients/allergy-treatment/oral-immunotherapy-for-food-allergy has been updated to include the following new information.

Considerations prior to commencing a food allergy OIT clinical trial

Food allergy OIT should be given in a consistent way, to maximise its chances of effectiveness and minimise the risk of side effects. Therefore, being in a food allergy OIT clinical trial may present difficulties for people who plan to go on active holidays, overnight excursions, camps, or board overnight at school. There will also be some inconveniences, potential lifestyle disruptions and restrictions while being in a food allergy OIT clinical trial that need to be carefully considered.

Each dose of OIT carries a risk of an allergic reaction, including anaphylaxis, so taking on responsibility for dosing a student taking food allergy OIT cannot be expected of every school. When students are on overnight school excursions or camps, there can be changes in sleep patterns, busy activity schedules, lower ratios of carers to students and remote or unfamiliar locations. These are all factors that can increase the risk of an allergic reaction with a dose of food allergy OIT. There also increased risks of an allergic reaction for a person on OIT who has an infection, poorly controlled asthma or allergic rhinitis.

Therefore, people on food allergy OIT may need to choose between attending school activities and interrupting OIT, depending on discussions with schools and camps or other factors. These factors should also be considered for people going on active holidays or other activities with their family or friends.

There are added risks when food allergy OIT is recommenced after a long interruption. For this reason, the OIT clinical trial doctor or treating clinical immunology/allergy specialist may recommend that this occurs in a supervised medical setting, in a similar way to a food allergen challenge. There are often long waiting times to access food allergen challenges outside of research settings. Therefore, a treating clinical immunology/allergy specialist may not be able to offer rapid access to a suitable setting for recommencing food allergy OIT when interruptions occur.

 

Mod ASCIA Member
Donate to AIFA
go to NAS website
About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditiation

healthdirect

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.